KaloBios Appoints Martin Shkreli As CEO, Obtains New Financing Commitment
Controversial biotech entrepreneur Martin Shkreli is hoping to resurrect the nearly-out-of-business biotech KaloBios ($KBIO), taking over as CEO after leading a group of investors to acquire a controlling stake.
Posted On Nov 20 2015